The Cambridge Historical Dictionary of Disease the Cambridge Historical Dictionary of Disease

Total Page:16

File Type:pdf, Size:1020Kb

The Cambridge Historical Dictionary of Disease the Cambridge Historical Dictionary of Disease THE CAMBRIDGE HISTORICAL DICTIONARY OF DISEASE THE CAMBRIDGE HISTORICAL DICTIONARY OF DISEASE Edited by KENNETHKENNETHF.KIPLE F. KIPLE Bowling Green State University Cambridge, New York, Melbourne, Madrid, Cape Town, Singapore, São Paulo Cambridge University Press The Edinburgh Building, Cambridge , United Kingdom Published in the United States of America by Cambridge University Press, New York www.cambridge.org Information on this title: www.cambridge.org/9780521808347 © Cambridge University Press 2003 This book is in copyright. Subject to statutory exception and to the provision of relevant collective licensing agreements, no reproduction of any part may take place without the written permission of Cambridge University Press. First published in print format 2003 - ---- eBook (Gale) - --- eBook (Gale) - ---- hardback - --- hardback - ---- paperback - --- paperback Cambridge University Press has no responsibility for the persistence or accuracy of s for external or third-party internet websites referred to in this book, and does not guarantee that any content on such websites is, or will remain, accurate or appropriate. In memory of K. David Patterson Contents Preface I xiii 15 Beriberi I 44 Melinda S. Meade 1 Acquired Immune Deficiency Syndrome (AIDS) I 1 16 Black Death I 49 Allan M. Brandt Katharine Park 2 African Trypanosomiasis (Sleeping 17 Black and Brown Lung Disease I 52 Sickness) I 7 Daniel M. Fox Maryinez Lyons 18 Bleeding Disorders I 54 3 Ainhum I 14 Oscar D. Ratnoff Donald B. Cooper 19 Botulism I 57 4 Alzheimer’s Disease I 14 WilliamH. Barker Joseph A. Kwentus 20 Brucellosis (Malta Fever, Undulant Fever) 5 Amebic Dysentery I 19 I 58 K. David Patterson Lise Wilkinson 6 Anemia I 21 21 Bubonic Plague I 60 Alfred Jay Bollet and Audrey K. Brown Ann G. Carmichael 7 Anorexia Nervosa I 26 22 Cancer I 63 Heather Munro Prescott Thomas G. Benedek and Kenneth F. Kiple 8 Anthrax I 29 23 Carrion’s Disease (Oroya Fever) I 67 Lise Wilkinson Oscar Urteaga-Ballon 9 Apoplexy and Stroke I 31 24 Catarrh I 69 Jacques Poirier and Christian Derouesne Roger K. French 10 Arboviruses I 34 25 Cestode Infection I 70 Wilbur G. Downs K. David Patterson 11 Arenaviruses I 38 26 Chagas’Disease I 70 Wilbur G. Downs Marvin J. Allison 12 Arthritis (Rheumatoid) I 39 27 Chlorosis I 71 Howard Duncan and James C. C. Leisen Robert P. Hudson 13 Ascariasis I 42 28 Cholera I 74 K. David Patterson Reinhard S. Speck 14 Bacillary Dysentery I 43 29 Cirrhosis I 79 K. David Patterson Thomas S. N. Chen and Peter S. Y. Chen vii Contents 30 Clonorchiasis I 81 48 Enterobiasis I 116 K. David Patterson K. David Patterson 31 Croup I 81 49 Epilepsy I 116 James D. Cherry Jerrold E. Levy 32 Cystic Fibrosis I 83 50 Ergotism I 120 Thomas G. Benedek John S. Haller, Jr. 33 Cytomegalovirus Infection I 84 51 Erysipelas I 121 R. H. Kampmeier Ann G. Carmichael 34 Dengue I 85 52 Fascioliasis I 123 James McSherry K. David Patterson I 35 Diabetes I 88 53 Fasciolopsiasis 123 Leslie Sue Lieberman K. David Patterson I 36 Diarrheal Diseases (Acute) I 92 54 Favism 123 Herbert L. DuPont Peter J. Brown 55 Filariasis I 125 37 Diphtheria I 94 Todd L. Savitt Ann G. Carmichael 56 Fungus Infections (Mycoses) I 128 38 Down Syndrome I 96 Geoffrey C. Ainsworth Christine E. Cronk 57 Fungus Poisoning I 132 39 Dracunculiasis I 98 Geoffrey C. Ainsworth Donald R. Hopkins 58 Gallstones (Cholelithiasis) I 134 40 Dropsy I 100 R. Ted Steinbock J. Worth Estes 59 Gangrene I 136 I 41 Dysentery 105 Diane Quintal and Robert Jackson K. David Patterson 60 Genetic Disease I 138 I 42 Dyspepsia 105 Eric J. Devor James Whorton 61 Giardiasis I 144 I 43 Ebola Virus Disease 107 K. David Patterson Wilbur G. Downs 62 Glomerulonephritis (Bright’s Disease) I 44 Echinococcosis (Hydatidosis) I 110 144 K. David Patterson Donald M. Larson 45 Eclampsia I 110 63 Goiter I 146 Sally McMillen Clark T. Sawin 46 Emphysema I 112 64 Gonorrhea I 150 Ronald J. Knudson Richard B. Rothenberg 47 Encephalitis Lethargica I 114 65 Gout I 153 R. T. Ravenholt Thomas G. Benedek viii Contents 66 Heart-Related Diseases I 156 83 Leprosy (Hansen’s Disease) I 192 Joel D. Howell Ann G. Carmichael 67 Herpes Simplex I 161 84 Leptospirosis I 195 R. H. Kampmeier Otto R. Gsell 68 Herpesviruses I 162 85 Leukemia I 196 R. H. Kampmeier Gordon J. Piller I 69 Histoplasmosis I 163 86 Lupus Erythematosus 199 Scott F. Davies Thomas G. Benedek 87 Lyme Borreliosis (Lyme Disease) I 201 70 Hookworm Infection I 165 Robert D. Leff John Ettling 88 Malaria I 203 71 Huntington’s Disease (Chorea) I 168 Frederick L. Dunn Eric J. Devor 89 Marburg Virus Disease I 207 I 72 Hypertension 169 Wilbur G. Downs Thomas W. Wilson and Clarence E. Grim 90 Mastoiditis I 208 I 73 Infectious Hepatitis 171 John L. Kemink, John K. Niparko, and Steven A. Francis L. Black Telian 74 Infectious Mononucleosis I 174 91 Measles I 211 R. H. Kampmeier Robert J. Kim-Farley 75 Inflammatory Bowel Disease (Crohn’s 92 Meningitis I 214 Disease, Ulcerative Colitis) I 175 K. David Patterson Joseph B. Kirsner 93 Milk Sickness (Tremetol Poisoning) I 218 76 Influenza I 178 Thomas E. Cone, Jr. Alfred W. Crosby 94 Multiple Sclerosis I 220 77 Japanese B Encephalitis I 181 W. I. McDonald Edward H. Kass 95 Mumps I 222 78 Lactose Intolerance and Malabsorption I Robert J. Kim-Farley 182 96 Muscular Dystrophy I 224 Norman Kretchmer Thomas G. Benedek I 79 Lassa Fever 184 97 Myasthenia Gravis I 225 Wilbur G. Downs Bernard M. Patten 80 Lead Poisoning I 185 98 Nematode Infection I 227 Arthur C. Aufderheide K. David Patterson 81 Legionnaires’Disease (Legionellosis, 99 Onchocerciasis I 228 Pontiac Fever, Legionella Pneumonia) I 189 K. David Patterson David W. Fraser 100 Ophthalmia (Trachoma, Conjunctivitis) 82 Leishmaniasis I 191 I 230 Marvin J. Allison Mary C. Karasch ix Contents 101 Osteoarthritis I 234 118 Rabies I 270 Charles W. Denko K. David Patterson 102 Osteoporosis I 236 119 Relapsing Fever I 275 R. Ted Steinbock Anne Hardy 103 Paget’s Disease of Bone I 238 120 Rheumatic Fever and Rheumatic Heart Roy D. Altman Disease I 277 Thomas G. Benedek 104 Paragonimiasis I 240 K. David Patterson 121 Rickets and Osteomalacia I 280 R. Ted Steinbock 105 Parkinson’s Disease (Parkinsonism) I 240 122 Rickettsial Diseases I 282 Bernard M. Patten Victoria A. Harden 106 Pellagra I 242 123 Rocky Mountain Spotted Fever and Elizabeth W. Etheridge Related Diseases I 283 Victoria A. Harden 107 Periodontal Disease (Pyorrhea) I 244 Jeffrey Levin 124 Rubella I 285 Robert J. Kim-Farley 108 Pica I 247 Brian T. Higgins 125 Saint Anthony’s Fire I 287 Ann G. Carmichael 109 Pinta I 250 Don R. Brothwell 126 Scarlet Fever I 288 Anne Hardy 110 Plague of Athens I 251 Ann G. Carmichael 127 Schistosomiasis I 290 John Farley 111 Pneumocystis Pneumonia (Interstitial Plasma Cell Pneumonia, Pneumocystosis) I 128 Scrofula I 292 254 Roger K. French K. David Patterson 129 Scurvy I 295 112 Pneumonia I 255 Roger K. French Jacalyn Duffin 130 Sickle-Cell Anemia I 298 113 Poliomyelitis I 258 Georges C. Benjamin H. V. Wyatt 131 Smallpox I 300 114 Protein-Energy Malnutrition I 261 Alfred W. Crosby James L. Newman 132 Streptococcal Diseases I 304 115 Protozoan Infection I 265 Peter C. English K. David Patterson 133 Strongyloidiasis I 306 116 Puerperal Fever I 265 K. David Patterson K. Codell Carter 134 Sudden Infant Death Syndrome (SIDS) 117 Q Fever I 267 I 306 S. R. Palmer Todd L. Savitt x Contents 135 Sudden Unexplained Death Syndrome 149 Trichuriasis I 336 (Asian SUDS) I 309 K. David Patterson Neal R. Holtan 150 Tuberculosis I 336 136 Sweating Sickness I 311 WilliamD. Johnston Ann G. Carmichael 151 Tularemia I 342 137 Syphilis I 312 Patrick D. Horne Jon Arrizabalaga 152 Typhoid Fever I 345 138 Syphilis, Nonvenereal I 317 Charles W. LeBaron and David N. Taylor Kenneth F. Kiple 153 Typhomalarial Fever I 349 I 139 Tapeworm Infection 319 Dale Smith K. David Patterson 154 Typhus, Epidemic I 352 I 140 Tay-Sachs Disease 320 Victoria A. Harden Bradford Towne 155 Typhus, Murine I 355 141 Tetanus I 323 Victoria A. Harden Robert J. T. Joy 156 Typhus, Scrub (Tsutsugamushi) I 355 142 Tetanus, Neonatal I 326 Victoria A. Harden Sally McMillen 157 Urolithiasis I 357 143 Tetany I 328 R. Ted Steinbock Kenneth F. Kiple 158 144 Toxoplasmosis I 330 Varicella-Zoster Virus Disease (Chickenpox) I 359 K. David Patterson R. H. Kampmeier 145 Trematode Infection I 331 I K. David Patterson 159 Whooping Cough 360 Anne Hardy 146 Trench Fever I 331 I Victoria A. Harden 160 Yaws 362 Don R. Brothwell 147 The Treponematoses I 331 Kenneth F. Kiple 161 Yellow Fever I 365 Donald B. Cooper and Kenneth F. Kiple 148 Trichinosis I 333 Donald E. Gilbertson Index I 371 xi Preface The Cambridge World History of Human Disease (CWHHD) was first pub- lished by Cambridge University Press in 1993 and reprinted in 2001. Part VIII, the last section of the work, comprises a history and description of the world’s major diseases of yesterday and today in chapters that are organized alphabetically from “Acquired Immune Deficiency Syndrome (AIDS)” to “Yellow Fever.” The pages that follow in this Dictionary rep- resent an effort to make these essays, along with three chapters from other parts of the CWHHD on “Heart-Related Diseases,” “Cancer,” and “Genetic Disease,” available to a wider audience in paperback form.
Recommended publications
  • Gouty Tophi on the Ear: a Review
    Gouty Tophi on the Ear: A Review Indy Chabra, MD, PhD; Rajendra Singh, MD Practice Points Consider gout in the differential of papulonodular lesions on the ear. If biopsying to rule out gout, fix the biopsy specimen in ethanol or Carnoy fixative to preserve birefrin- gence of urate crystals. Although the classic location of gouty tophi is the and gout. Presentation of gout in younger patients great toe (podagra), gouty tophi of the ear also is without these risk factors should raise suspicion of common and is worth including in the differential renal disease or an underlying enzyme deficiency, diagnosis in patients presenting with ear lesions. such as hypoxanthine guanine phosphoribosyl- Other entities presenting as papules or nodules transferase deficiency in X-linked recessive Lesch- on the ear include chondrodermatitis nodularis Nyhan syndrome.3 helicis (CNH), actinic keratosis, basal cell carci- noma, squamous cell carcinoma,CUTIS verruca vulgaris, Clinical Features amyloids, rheumatoid nodules, and elastotic nod- Gouty tophi classically present as hard, yellow-white ules. If tophaceous gout is suspected, alcohol papules and nodules of a chalky consistency on the fixation of the biopsy specimen is preferable, as joints of the hands and feet. Less common locations it enables visualization of characteristic needle- for gouty tophi include the ears, elbows (olecranon shaped urate crystals. bursae), and the Achilles tendon. Decreased tem- Cutis. 2013;92:190-192. perature and reduced blood flow in these areas may Do Notexplain Copy the predilection for these locations. The ears are the most common location for gouty tophi in the out is the most common cause of inflamma- head and neck region and may be a heralding sign tory arthritis in men and classically presents of gout.4 Auricular tophi usually are located on the Gas painful acute monoarthritis of the great toe helical rims but also may be located on the antihe- (podagra) or the knee.
    [Show full text]
  • Kellie ID Emergencies.Pptx
    4/24/11 ID Alert! recognizing rapidly fatal infections Susan M. Kellie, MD, MPH Professor of Medicine Division of Infectious Diseases, UNMSOM Hospital Epidemiologist UNMHSC and NMVAHCS Fever and…. Rash and altered mental status Rash Muscle pain Lymphadenopathy Hypotension Shortness of breath Recent travel Abdominal pain and diarrhea Case 1. The cross-country trucker A 30 year-old trucker driving from Oklahoma to California is hospitalized in Deming with fever and headache He is treated with broad-spectrum antibiotics, but deteriorates with obtundation, low platelet count, and a centrifugal petechial rash and is transferred to UNMH 1 4/24/11 What is your diagnosis? What is the differential diagnosis of fever and headache with petechial rash? (in the US) Tickborne rickettsioses ◦ RMSF Bacteria ◦ Neisseria meningitidis Key diagnosis in this case: “doxycycline deficiency” Key vector-borne rickettsioses treated with doxycycline: RMSF-case-fatality 5-10% ◦ Fever, nausea, vomiting, myalgia, anorexia and headache ◦ Maculopapular rash progresses to petechial after 2-4 days of fever ◦ Occasionally without rash Human granulocytotropic anaplasmosis (HGA): case-fatality<1% Human monocytotropic ehrlichiosis (HME): case fatality 2-3% 2 4/24/11 Lab clues in rickettsioses The total white blood cell (WBC) count is typicallynormal in patients with RMSF, but increased numbers of immature bands are generally observed. Thrombocytopenia, mild elevations in hepatic transaminases, and hyponatremia might be observed with RMSF whereas leukopenia
    [Show full text]
  • Bioimpedance Monitoring System for Pervasive Biomedical Applications
    Bioimpedance monitoring system for pervasive biomedical applications Jaime Punter Villagrasa ADVERTIMENT . La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió d’aquesta tesi per mitjà del servei TDX ( www.tdx.cat ) i a través del Dipòsit Digital de la UB ( diposit.ub.edu ) ha estat autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en ac tivitats d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposici ó des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB . No s’autoritza la presentació del seu contingut en una finestra o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora . ADVERTENCIA . La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La difusión de esta tesis por medio del servicio TDR ( www.tdx.cat ) y a través del Repositorio Digital de la UB ( diposit.ub.edu ) ha sido auto rizada por los titulares de los derechos de propiedad intelectual únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro ni su difusión y puesta a disposición desde un si tio ajeno al servicio TDR o al Repositorio Digital de la UB .
    [Show full text]
  • Psoriasis, a Systemic Disease Beyond the Skin, As Evidenced by Psoriatic Arthritis and Many Comorbities
    1 Psoriasis, a Systemic Disease Beyond the Skin, as Evidenced by Psoriatic Arthritis and Many Comorbities – Clinical Remission with a Leishmania Amastigotes Vaccine, a Serendipity Finding J.A. O’Daly Astralis Ltd, Irvington, NJ USA 1. Introduction Psoriasis is a systemic chronic, relapsing inflammatory skin disorder, with worldwide distribution, affects 1–3% of the world population, prevalence varies according to race, geographic location, and environmental factors (Chandran & Raychaudhuri, 2010; Christophers & Mrowietz, 2003; Farber & Nall, 1974). In Germany, 33,981 from 1,344,071 continuously insured persons in 2005 were diagnosed with psoriasis; thus the one year prevalence was 2.53% in the study group. Up to the age of 80 years the prevalence rate (range: 3.99-4.18%) was increasing with increasing age and highest for the age groups from 50 to 79 years The total rate of psoriasis in children younger than 18 years was 0.71%. The prevalence rates increased in an approximately linear manner from 0.12% at the age of 1 year to 1.2% at the age of 18 years (Schäfer et al., 2011). In France, a case-control study in 6,887 persons, 356 cases were identified (5.16%), who declared having had psoriasis during the previous 12 months (Wolkenstein et al., 2009). The prevalence of psoriasis analyzed across Italy showed that 2.9% of Italians declared suffering from psoriasis (regional range: 0.8-4.5%) in a total of 4109 individuals (Saraceno et al., 2008). The overall rate of comorbidity in subjects with psoriasis aged less than 20 years was twice as high as in subjects without psoriasis.
    [Show full text]
  • Problem of Creating a Professional Dictionary of Uncodified Vocabulary
    Utopía y Praxis Latinoamericana ISSN: 1315-5216 ISSN: 2477-9555 [email protected] Universidad del Zulia Venezuela Problem of Creating a Professional Dictionary of Uncodified Vocabulary MOROZOVA, O.A; YAKHINA, A.M; PESTOVA, M.S Problem of Creating a Professional Dictionary of Uncodified Vocabulary Utopía y Praxis Latinoamericana, vol. 25, no. Esp.7, 2020 Universidad del Zulia, Venezuela Available in: https://www.redalyc.org/articulo.oa?id=27964362018 DOI: https://doi.org/10.5281/zenodo.4009661 This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International. PDF generated from XML JATS4R by Redalyc Project academic non-profit, developed under the open access initiative O.A MOROZOVA, et al. Problem of Creating a Professional Dictionary of Uncodified Vocabulary Artículos Problem of Creating a Professional Dictionary of Uncodified Vocabulary Problema de crear un diccionario profesional de vocabulario no codificado O.A MOROZOVA DOI: https://doi.org/10.5281/zenodo.4009661 Kazan Federal University, Rusia Redalyc: https://www.redalyc.org/articulo.oa? [email protected] id=27964362018 http://orcid.org/0000-0002-4573-5858 A.M YAKHINA Kazan Federal University, Rusia [email protected] http://orcid.org/0000-0002-8914-0995 M.S PESTOVA Ural State Law University, Rusia [email protected] http://orcid.org/0000-0002-7996-9636 Received: 03 August 2020 Accepted: 10 September 2020 Abstract: e article considers the problem of lexicographical fixation of uncodified vocabulary in a professional dictionary. e oil sublanguage, being one of the variants of common language realization used by a limited group of its medium in conditions of official and also non-official communication, provides interaction of people employed in the oil industry.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • How Do We Treat Life-Threatening Anemia in a Jehovah's Witness
    HOW DO I...? How do we treat life-threatening anemia in a Jehovah’s Witness patient? Joseph A. Posluszny Jr and Lena M. Napolitano he management of Jehovah’s Witness (JW) The refusal of allogeneic human blood and blood prod- patients with anemia and bleeding presents a ucts by Jehovah’s Witness (JW) patients complicates clinical dilemma as they do not accept alloge- the treatment of life-threatening anemia. For JW neic human blood or blood product transfu- patients, when hemoglobin (Hb) levels decrease Tsions.1,2 With increased understanding of the JW patient beyond traditional transfusion thresholds (<7 g/dL), beliefs and blood product limitations, the medical com- alternative methods to allogeneic blood transfusion can munity can better prepare for optimal treatment of severe be utilized to augment erythropoiesis and restore life-threatening anemia in JW patients. endogenous Hb levels. The use of erythropoietin- Lower hemoglobin (Hb) is associated with increased stimulating agents and intravenous iron has been mortality risk in JW patients. In a study of 300 patients shown to restore red blood cell and Hb levels in JW who refused blood transfusion, for every 1 g/dL decrease patients, although these effects may be significantly in Hb below 8 g/dL, the odds of death increased 2.5-fold delayed. When JW patients have evidence of life- (Fig. 1).3 A more recent single-center update of JW threatening anemia (Hb <5 g/dL), oxygen-carrying patients (n = 293) who declined blood transfusion capacity can be supplemented with the administration reported an overall mortality rate of 8.2%, with a twofold of Hb-based oxygen carriers (HBOCs).
    [Show full text]
  • Fleas and Flea-Borne Diseases
    International Journal of Infectious Diseases 14 (2010) e667–e676 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Review Fleas and flea-borne diseases Idir Bitam a, Katharina Dittmar b, Philippe Parola a, Michael F. Whiting c, Didier Raoult a,* a Unite´ de Recherche en Maladies Infectieuses Tropicales Emergentes, CNRS-IRD UMR 6236, Faculte´ de Me´decine, Universite´ de la Me´diterrane´e, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France b Department of Biological Sciences, SUNY at Buffalo, Buffalo, NY, USA c Department of Biology, Brigham Young University, Provo, Utah, USA ARTICLE INFO SUMMARY Article history: Flea-borne infections are emerging or re-emerging throughout the world, and their incidence is on the Received 3 February 2009 rise. Furthermore, their distribution and that of their vectors is shifting and expanding. This publication Received in revised form 2 June 2009 reviews general flea biology and the distribution of the flea-borne diseases of public health importance Accepted 4 November 2009 throughout the world, their principal flea vectors, and the extent of their public health burden. Such an Corresponding Editor: William Cameron, overall review is necessary to understand the importance of this group of infections and the resources Ottawa, Canada that must be allocated to their control by public health authorities to ensure their timely diagnosis and treatment. Keywords: ß 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Flea Siphonaptera Plague Yersinia pestis Rickettsia Bartonella Introduction to 16 families and 238 genera have been described, but only a minority is synanthropic, that is they live in close association with The past decades have seen a dramatic change in the geographic humans (Table 1).4,5 and host ranges of many vector-borne pathogens, and their diseases.
    [Show full text]
  • The Intestinal Protozoa
    The Intestinal Protozoa A. Introduction 1. The Phylum Protozoa is classified into four major subdivisions according to the methods of locomotion and reproduction. a. The amoebae (Superclass Sarcodina, Class Rhizopodea move by means of pseudopodia and reproduce exclusively by asexual binary division. b. The flagellates (Superclass Mastigophora, Class Zoomasitgophorea) typically move by long, whiplike flagella and reproduce by binary fission. c. The ciliates (Subphylum Ciliophora, Class Ciliata) are propelled by rows of cilia that beat with a synchronized wavelike motion. d. The sporozoans (Subphylum Sporozoa) lack specialized organelles of motility but have a unique type of life cycle, alternating between sexual and asexual reproductive cycles (alternation of generations). e. Number of species - there are about 45,000 protozoan species; around 8000 are parasitic, and around 25 species are important to humans. 2. Diagnosis - must learn to differentiate between the harmless and the medically important. This is most often based upon the morphology of respective organisms. 3. Transmission - mostly person-to-person, via fecal-oral route; fecally contaminated food or water important (organisms remain viable for around 30 days in cool moist environment with few bacteria; other means of transmission include sexual, insects, animals (zoonoses). B. Structures 1. trophozoite - the motile vegetative stage; multiplies via binary fission; colonizes host. 2. cyst - the inactive, non-motile, infective stage; survives the environment due to the presence of a cyst wall. 3. nuclear structure - important in the identification of organisms and species differentiation. 4. diagnostic features a. size - helpful in identifying organisms; must have calibrated objectives on the microscope in order to measure accurately.
    [Show full text]
  • A Clinical Case of Fournier's Gangrene: Imaging Ultrasound
    J Ultrasound (2014) 17:303–306 DOI 10.1007/s40477-014-0106-5 CASE REPORT A clinical case of Fournier’s gangrene: imaging ultrasound Marco Di Serafino • Chiara Gullotto • Chiara Gregorini • Claudia Nocentini Received: 24 February 2014 / Accepted: 17 March 2014 / Published online: 1 July 2014 Ó Societa` Italiana di Ultrasonologia in Medicina e Biologia (SIUMB) 2014 Abstract Fournier’s gangrene is a rapidly progressing Introduction necrotizing fasciitis involving the perineal, perianal, or genital regions and constitutes a true surgical emergency Fournier’s gangrene is an acute, rapidly progressive, and with a potentially high mortality rate. Although the diagnosis potentially fatal, infective necrotizing fasciitis affecting the of Fournier’s gangrene is often made clinically, emergency external genitalia, perineal or perianal regions, which ultrasonography and computed tomography lead to an early commonly affects men, but can also occur in women and diagnosis with accurate assessment of disease extent. The children [1]. Although originally thought to be an idio- Authors report their experience in ultrasound diagnosis of pathic process, Fournier’s gangrene has been shown to one case of Fournier’s gangrene of testis illustrating the main have a predilection for patients with state diabetes mellitus sonographic signs and imaging diagnostic protocol. as well as long-term alcohol misuse. However, it can also affect patients with non-obvious immune compromise. Keywords Fournier’s gangrene Á Sonography Comorbid systemic disorders are being identified more and more in patients with Fournier’s gangrene. Diabetes mel- Riassunto La gangrena di Fournier e` una fascite necro- litus is reported to be present in 20–70 % of patients with tizzante a rapida progressione che coinvolge il perineo, le Fournier’s Gangrene [2] and chronic alcoholism in regioni perianale e genitali e costituisce una vera emer- 25–50 % patients [3].
    [Show full text]
  • Methods in Lexicography and Dictionary Research* Stefan J
    Methods in Lexicography and Dictionary Research* Stefan J. Schierholz, Department Germanistik und Komparatistik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany ([email protected]) Abstract: Methods are used in every stage of dictionary-making and in every scientific analysis which is carried out in the field of dictionary research. This article presents some general consid- erations on methods in philosophy of science, gives an overview of many methods used in linguis- tics, in lexicography, dictionary research as well as of the areas these methods are applied in. Keywords: SCIENTIFIC METHODS, LEXICOGRAPHICAL METHODS, THEORY, META- LEXICOGRAPHY, DICTIONARY RESEARCH, PRACTICAL LEXICOGRAPHY, LEXICO- GRAPHICAL PROCESS, SYSTEMATIC DICTIONARY RESEARCH, CRITICAL DICTIONARY RESEARCH, HISTORICAL DICTIONARY RESEARCH, RESEARCH ON DICTIONARY USE Opsomming: Metodes in leksikografie en woordeboeknavorsing. Metodes word gebruik in elke fase van woordeboekmaak en in elke wetenskaplike analise wat in die woor- deboeknavorsingsveld uitgevoer word. In hierdie artikel word algemene oorwegings vir metodes in wetenskapfilosofie voorgelê, 'n oorsig word gegee van baie metodes wat in die taalkunde, leksi- kografie en woordeboeknavorsing gebruik word asook van die areas waarin hierdie metodes toe- gepas word. Sleutelwoorde: WETENSKAPLIKE METODES, LEKSIKOGRAFIESE METODES, TEORIE, METALEKSIKOGRAFIE, WOORDEBOEKNAVORSING, PRAKTIESE LEKSIKOGRAFIE, LEKSI- KOGRAFIESE PROSES, SISTEMATIESE WOORDEBOEKNAVORSING, KRITIESE WOORDE- BOEKNAVORSING, HISTORIESE WOORDEBOEKNAVORSING, NAVORSING OP WOORDE- BOEKGEBRUIK 1. Introduction In dictionary production and in scientific work which is carried out in the field of dictionary research, methods are used to reach certain results. Currently there is no comprehensive and up-to-date documentation of these particular methods in English. The article of Mann and Schierholz published in Lexico- * This article is based on the article from Mann and Schierholz published in Lexicographica 30 (2014).
    [Show full text]
  • Celiac Disease and Nonceliac Gluten Sensitivitya Review
    Clinical Review & Education JAMA | Review Celiac Disease and Nonceliac Gluten Sensitivity A Review Maureen M. Leonard, MD, MMSc; Anna Sapone, MD, PhD; Carlo Catassi, MD, MPH; Alessio Fasano, MD CME Quiz at IMPORTANCE The prevalence of gluten-related disorders is rising, and increasing numbers of jamanetwork.com/learning individuals are empirically trying a gluten-free diet for a variety of signs and symptoms. This review aims to present current evidence regarding screening, diagnosis, and treatment for celiac disease and nonceliac gluten sensitivity. OBSERVATIONS Celiac disease is a gluten-induced immune-mediated enteropathy characterized by a specific genetic genotype (HLA-DQ2 and HLA-DQ8 genes) and autoantibodies (antitissue transglutaminase and antiendomysial). Although the inflammatory process specifically targets the intestinal mucosa, patients may present with gastrointestinal signs or symptoms, extraintestinal signs or symptoms, or both, Author Affiliations: Center for Celiac suggesting that celiac disease is a systemic disease. Nonceliac gluten sensitivity Research and Treatment, Division of is diagnosed in individuals who do not have celiac disease or wheat allergy but who Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for have intestinal symptoms, extraintestinal symptoms, or both, related to ingestion Children, Boston, Massachusetts of gluten-containing grains, with symptomatic improvement on their withdrawal. The (Leonard, Sapone, Catassi, Fasano); clinical variability and the lack of validated biomarkers for nonceliac gluten sensitivity make Celiac Research Program, Harvard establishing the prevalence, reaching a diagnosis, and further study of this condition Medical School, Boston, Massachusetts (Leonard, Sapone, difficult. Nevertheless, it is possible to differentiate specific gluten-related disorders from Catassi, Fasano); Shire, Lexington, other conditions, based on currently available investigations and algorithms.
    [Show full text]